Therapeutic Potential of Venetoclax and Selinexor in Targeting Hypoxia‐Induced Vulnerabilities in Multiple Myeloma
ABSTRACT Background Multiple myeloma (MM) is a blood cancer marked by the abnormal clonal growth of plasma cells. Hypoxia plays a critical role in the progression and treatment resistance of MM. Aims This study investigates the expression of B‐cell/CLL lymphoma 2 (BCL2) family genes. We also investi...
Zapisane w:
| Główni autorzy: | , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Wiley
2025-06-01
|
| Seria: | Cancer Reports |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1002/cnr2.70249 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
